Stockreport

Galera Adopts Limited Duration Stockholder Rights Agreement

Galera Therapeutics, Inc.  (GRTX) 
PDF MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprie [Read more]